Renishaw plc with ticker (LON:RSW) now has a potential downside of -12.5% according to Barclays.
Barclays set a target price of 4,695 GBX for the company, which when compared to the Renishaw plc share price of 5,280 GBX at opening today (27/10/2021) indicates a potential downside of -12.5%. Trading has ranged between 4,316 (52 week low) and 7,025 (52 week high) with an average of 73,373 shares exchanging hands daily. The market capitalisation at the time of writing is £3,785,731,965.
Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations. The Company’s metrology products include co-ordinate measuring machine products, machine tool probe systems, styli for probe systems, performance testing products, gauging, spatial measurement, fixtures, position encoders, additive manufacturing and vacuum casting. It serves various markets, such as automotive, power generation, aerospace, agriculture, construction and resource exploration.
Renishaw plc -12.5% potential downside indicated by Barclays
[shareaholic app="share_buttons" id_name="post_below_content"]
- Written by: Anthony Fox
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Renishaw plc (LON:RSW) has released a trading update for the nine months ended 31 March 2024, showing solid performance and signs of semiconductor equipment recovery.
Renishaw plc has released its interim report for the six months ended December 31, 2023. Revenue decreased by 5% to £330.5m, with various factors impacting the results.